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Abstract
Background: Propolis is a complex resinous honeybee product. It is reported to display diverse bioactivities, such
as antimicrobial, anti-inflammatory and anti-tumor properties, which are mainly due to phenolic compounds, and
especially flavonoids. The diversity of bioactive compounds depends on the geography and climate, since these
factors affect the floral diversity. Here, Apis mellifera propolis from Nan province, Thailand, was evaluated for
potential anti-cancer activity.
Methods: Propolis was sequentially extracted with methanol, dichloromethane and hexane and the cytotoxic
activity of each crude extract was assayed for antiproliferative/cytotoxic activity in vitro against five human cell lines
derived from duet carcinoma (BT474), undifferentiated lung (Chaco), liver hepatoblastoma (Hep-G2), gastric
carcinoma (KATO-III) and colon adenocarcinoma (SW620) cancers. The human foreskin fibroblast cell line (Hs27) was
used as a non-transformed control. Those crude extracts that displayed antiproliferative/cytotoxic activity were then
further fractionated by column chromatography using TLC-pattern and MTT-cytotoxicity bioassay guided selection
of the fractions. The chemical structure of each enriched bioactive compound was analyzed by nuclear magnetic
resonance and mass spectroscopy.
Results: The crude hexane and dichloromethane extracts of propolis displayed antiproliferative/cytotoxic activities
with IC50 values across the five cancer cell lines ranging from 41.3 to 52.4 μg/ml and from 43.8 to 53.5 μg/ml,
respectively. Two main bioactive components were isolated, one cardanol and one cardol, with broadly similar in
vitro antiproliferation/cytotoxicity IC50 values across the five cancer cell lines and the control Hs27 cell line, ranging
from 10.8 to 29.3 μg/ml for the cardanol and < 3.13 to 5.97 μg/ml (6.82 - 13.0 μM) for the cardol. Moreover, both
compounds induced cytotoxicity and cell death without DNA fragmentation in the cancer cells, but only an
antiproliferation response in the control Hs27 cells However, these two compounds did not account for the net
antiproliferation/cytotoxic activity of the crude extracts suggesting the existence of other potent compounds or
synergistic interactions in the propolis extracts.
Conclusion: This is the first report that Thai A. mellifera propolis contains at least two potentially new compounds
(a cardanol and a cardol) with potential anti-cancer bioactivity. Both could be alternative antiproliferative agents for
future development as anti-cancer drugs.
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Propolis is a sticky resin produced by various bee spe-
cies and is mainly derived from the resins collected by
bees from the buds and barks of trees [1]. It is used for
the construction and repair of hives [2] and is consid-
ered to act as a protective barrier against contaminating
microorganisms [3]. Propolis from various geographical
locations, bee species and seasons, as well as their
extracts, have been reported to exhibit a diverse array of
bioactivities, such as antibacterial [4], antifungal [5],
antiparasitic [6], free radical scavenging [7], anti-inflam-
matory [8] and antiproliferative [9] activities. Due to the
broad range of bioactivities ascribed to propolis, it has
long been used in traditional medicine [10]. Further-
more, at present, propolis is deemed to be acceptable
for use in foods, such as beverages, health foods and
nutritional supplements, as well as in cosmetics and per-
sonal hygiene products like toothpaste and soap.
Propolis typically consists of resin and balsam (50%),
wax (30%), oil (10%), pollen (5%) and other (5%) minor
components [11]. The main bioactive chemical com-
pounds in propolis are reported to be phenolic acid, ter-
penes, cinnamic acid, caffeic acid, several esters and
flavonoids, the last of which includes flavones, flava-
nones, flavonols, dihydroflavonols and chalcones [12,13].
However, the chemical composition of propolis is quali-
tatively and quantitatively variable, depending on the
available floral diversity at the location, the bee species
and the season of collection [14,15]. Because the diverse
array and types of chemical components in propolis
vary in size and polarity, the solvents used to extract the
propolis play a key role in the bioactivities, including
anti-cancer activities, that are obtained in the crude
extracts or subsequent fractions [16], due to the differ-
ential fractionation of components between different
extracting solvents. In addition to organic solvents,
edible vegetable oils, triglycerides and fatty acids have
been used to extract propolis [9]. Given that bioactivity
guided fractionation processes are commonly used to
meet the logistic demands of enriching such a complex
mixture of components, it is important to note that dif-
ferent cell lines have been reported to vary in their sen-
sitivity to each of the different bioactive compounds
isolated from propolis. Regardless, caffeic acid phenethyl
ester (CAPE) currently seems to be the most interesting
component isolated from propolis and is currently being
developed as a potential anti-cancer drug since it can
inhibit the in vitro growth of many cell lines [17] includ-
ing the estrogen receptor positive (ER
+)a n dn e g a t i v e
(ER
-) MCF7 and MDA231 cell lines, respectively [18],
along with the chemoresistant PANC-1 cell line [19].
The mechanism of how CAPE inhibits the growth of
cancer cell lines has been widely studied. In addition,
CAPE has been reported to only be cytotoxic to cancer
cell lines and not to normal cells in vitro [20,21], and
this is additionally supported by the results from the
systemic in vivo administration of CAPE [22]. Other
than CAPE, artepillin C from Brazilian green propolis
was reported to almost completely suppress the growth
of human neurofibromatosis tumor xenografts in mice
by blocking the oncogenic PAK1 signaling pathway [23].
Furthermore, the oil extract of Brazilian propolis, of
which the significant bioactive compound is artepillin C,
could effectively inhibit sarcoma 180 ascites tumor cells
in male Swiss mice [9].
In contrast to Western medicine, traditional folklore
based Eastern medicine is generally based upon the use
of extracts from natural sources that consist of multiple
components. Although their effects are not acute or
their side effect(s) can be delayed, their chronic usage
can result in the gradual accumulation of toxic com-
pounds [24]. For example, with respect to propolis it
has been shown that two caffeic acid esters in poplar
propolis, prenyl caffeate isomers and phenylethyl caffe-
ate, can act as allergens and sensitize individuals [25].
Thus, minimizing the allergen content in propolis or its
extracts is important [26]. In contrast, although pure
chemicals are used in Western medicine, which then
avoids this type of problem along with antagonistic or
undesired (non-intended) side affects, their effects are
acute and side effects, especially the selection for che-
moresistant cancers and antibiotic-resistant bacteria, are
still highly problematical. Thus, it is important to find
new classes of agents, such as those with different target
sites or modes of action, in order to relieve this
problem.
In this research, we aimed to isolate compounds with
anti-proliferative/cytotoxic activities against human can-
cer cells from A. mellifera propolis collected from within
the Nan province in Northern Thailand. Propolis was
extracted sequentially with three solvents of decreasing
polarity, and the crude extracts screened for antiproli-
ferative/cytotoxic activity against five human cancer cell
lines using the 3- (4, 5-dimethyl-thiazol-2-yl) 2, 5-diphe-
nyl-tetrazolium bromide (MTT) assay. The crude propo-
lis extract that displayed significant antiproliferative/
cytotoxic activity was then further fractionated by col-
umn chromatography, using thin layer chromatography
(TLC) pattern profiling and MTT bioassay guided selec-
tion of the fractions. The apparently pure bioactive frac-
tions were then characterized for their formula structure
by nuclear magnetic resonance (NMR) and electrospray
ionization mass spectrometry (EIS-MS), whilst their in
vitro cytotoxicity against the five human cancer cell
lines was evaluated in comparison to a non-transformed
(normal) human cell line using the MTT assay and
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fragmentation pattern.
Methods
Propolis collection
Propolis of Apis mellifera was collected from an apiary
in Pua district, Nan province, Thailand, during January
28 - February 1, 2010. It was kept in the dark by wrap-
ping with aluminium foil until used.
Bioassay-guided isolation (partition)
The extraction procedure essentially followed that
reported by Umthong et al. [27] and Najafi et al. [28].
Propolis (90 g) was stirred with 400 ml of 80% (v/v)
methanol (MeOH) at 100 rpm, 15°C for 18 h and then
clarified by centrifugation at 7,000 rpm, 20°C for 15
min. The extract (supernatant) was harvested and the
solvent removed by low pressure evaporation to leave
the crude MeOH extract of propolis (CME). The resi-
dual propolis (pellet) was then sequentially extracted in
the same way with 400 ml of dichloromethane (CH2Cl2)
followed by hexane to yield the crude CH2Cl2 extract
(CDE) and crude hexane extract (CHE), respectively. All
three crude extracts were kept in the dark at -20°C until
they were tested for their antiproliferation/cytotoxicity
activity by the MTT assay.
Chromatography
Quick column chromatography
A sintered glass (250 ml) column (0.063 - 0.2 mm in
size, Merck) was tightly packed with silica gel 60 G
using a vacuum pump. The crude propolis extract
(CHE, CDE or CME) was mixed with silica gel 60 to a
paste, left to dry and then sprinkled onto the packed
column followed by a piece of filter paper (110 mm in
Ø) and a cotton plug. The column was then eluted with
a stepwise mobile phase of 1.5 L of each of 0:1, 1:3, 1:1,
3:1 and 1:0 (v/v) CH2Cl2: hexane, followed by 3:7 (v/v)
MeOH: CH2Cl2, collecting 500 ml fractions. The purity
of each fraction was determined by TLC (described
below), and fractions with the same TLC profile pattern
were pooled prior to solvent removal by low pressure
evaporation. Fractions were then screened for antiproli-
feration/cytotoxic activity using the MTT assay as
detailed below.
Adsorption chromatography
A silica gel 60 (90 g) column (250 ml) in hexane was
prepared as described above. Fractions which showed a
good antiproliferation/cytotoxic activity were dissolved
in the appropriate solvent, mixed with silica gel 60 (5-7
g) and left at room temperature (RT) until dry. They
were then transferred to the column and eluted as
above except the stepwise elution gradient was com-
prised of 500 ml of 0:1, 1:1 and 1:0 (v/v) CH2Cl2: hexane
and finally MeOH, and 2.5 ml fractions were collected.
Fractions were screened for component composition by
TLC profile patterns, with those with similar TLC pro-
files being pooled and then screened for antiprolifera-
tive/cytotoxic activity using the MTT assay.
Thin layer chromatography (TLC)
TLC plates (a silica coated plate, Merck) were cut to 5 ×
5c m
2 and each sample was loaded by a capillary tube
onto five replicate plates. One of each of the five repli-
cate plates was then resolved in a mobile phase of one
of 0:1, 1:1, 3:1 and 1:0 (v/v) CH2Cl2: hexane or 1:19 (v/
v) MeOH: CH2Cl2, respectively. After the mobile phase
solvent permeated to the top line of the TLC plate, the
TLC plate was removed, left at RT to dry and then the
resolved compounds were visualized and location
marked under ultraviolet light.
Antiproliferation and cytotoxicity assays against human
cancer cell lines
Transformed (cancer) and non-transformed cell lines
The five selected cancer cell lines used in this research
were derived from human duet carcinoma (BT474,
ATCC No. HTB 20), undifferentiated lung (Chaco I,
National Cancer Institute), liver hepatoblastoma (Hep-
G2, ATCC No. HB8065), gastric carcinoma (KATO-III,
ATCC No. HTB 103) and human colon adenocarcinoma
(SW620, ATCC No. CCL 227) cancers. In addition, the
non-transformed human foreskin fibroblast cell line
(Hs27, ATCC No. CRL 1634) was used as a comparative
control. All cell lines were obtained from the Institute
of Biotechnology and Genetic Engineering, Chulalong-
korn University. The five cancer cell lines were cultured
in RPMI 1640 medium containing 5% (v/v) fetal calf
serum (FCS), while the Hs27 cell line was cultured in
Basal Iscove medium containing 5% (v/v) FCS, at 37°C
with 5% (v/v) CO2 [28].
Cell counts
Cells were removed from their culture flask using stan-
dard trypsin treatment until dislodged with gentle
aspiration into single cell suspensions and resuspended
to ten-fold the initial volume, or as appropriate, to allow
counting on an improved Neubauer counting chamber.
Cells positioning at four large corner squares of the
hematocytometer were counted and so the number of
cells was calculated as:
Concentration ofcells(cells/ml) = (Numberofcells/4) × dilutionfactor × 104 cells/ml

3 − (4, 5 − dimethyl − thiazol − 2 − yl)2,5 − diphenyl − tetrazoliumbromide

(MTT)assay
T h eM T Ta s s a yw a sp e r f o r m e da sr e p o r t e db yS a n t o s
et al. [29] and Hernandez et al. [17]. For each of the five
cancer cell lines, 5 × 10
3 cells in 200 μl of RPMI 1640
medium containing 5% (v/v) FCS were transferred per
well of a 96 well tissue culture plate, and incubated at
37°C in 5% (v/v) CO2 for 24 h prior to the addition of 2
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at various final concentrations. The addition of 2 μl/well
of DMSO alone was used as the control. Cells were
then incubated as above for 72 h before 10 μlo f5m g /
ml MTT was added and incubated for another 4 h. The
supernatant was then removed, the cells permeabilized
and the formazan crystals dissolved by aspiration in 150
μl of DMSO and 25 μl of 0.1 M glycine prior to measur-
ing the absorbance at 540 nm by a microplate reader.
Three replications of each trial were performed. By
assuming an equal mitochondrial metabolic activity per
living cell, the absorbance is then related to the relative
number of viable cells and so is reduced, relative to the
control, by any antiproliferation and/or cytotoxic activity
of the test compound.
Estimation of the inhibition concentration at 50% (IC50)
The absorbance at 540 nm of the test compound treated
cancer cells and the solvent only control was used to
calculate the relative number of viable cells, setting that
for the control as 100%. The relative number of viable
cells, as a % of the control, was then calculated as fol-
lows:
Therelative(% )numberofviablecells =
(Absofsample) × 100
(Absofcontrol)
where (Abs of sample) and (Abs of control) are
defined as the absorbance at 540 nm of the treated cells
and the control cells, respectively.
The IC50 values were graphically obtained by plotting
the absorbance obtained against the corresponding dif-
ferent concentrations of the test compound used, and
are reported as the mean ± 1 standard error (SE). Data
were statistically analyzed using the Kruskal-Wallis One
Way Analysis of Variance. Significance was accepted at
the P < 0.05 level.
Chemical structure analysis by spectroscopy
Nuclear magnetic resonance (NMR)
To analyze the enriched bioactive compounds, 2-3 mg
of each purified active fraction was dissolved in 500 μl
of deuterated chloroform (CDCl3) and transferred into
an NMR tube. The sample was analyzed and recorded
by a Varian Mercury
+ 400 NMR spectrometer operating
at 400 MHz for
1Ha n d2 DN M R( C O S Y ,H S Q C ,
HMBC) and 100 MHz for
13 C nuclei in order to search
for functional groups. The chemical shift in δ (ppm) was
assigned with reference to the signal from the residual
protons in the deuterated solvent and TMS was used as
an internal standard.
Mass spectroscopy (MS)
For each purified fraction a 1-2 mg aliquot was dis-
solved in ethyl acetate (1 ml) and was then commer-
cially analyzed at the National Science and Technology
Development Agency (NSTDA, Thailand) using ESI-MS
to evaluate the molecular weight and functional group
composition.
DNA fragmentation
The SW620 cancer cells or untransformed Hs27 cells (5
×1 0
5 cells/flask/6 ml media) were cultured as above for
24 h and then exposed to the test fraction at the derived
antiproliferation/cytotoxic IC50 concentration for 72 h,
observing their morphology and cell number every 24 h.
The morphology of the SW620 or Hs27 cells treated
with each test compound was compared to those treated
with only the DMSO solvent as the control. Cells were
released by standard trypsin and aspiration, centrifugally
washed at 2,000 × g at 15-25°C for 5 min and finally the
cell pellet was resuspended in 200 μl of PBS. To this 20
μl of proteinase K (> 600 mAU/ml) was added and total
DNA was extracted using a QIAMP mini kit (Qiagen,
cat. no. 51304), as per the manufacturer’si n s t r u c t i o n s .
The extracted DNA was stored at -20°C until used, with
the concentration and purity being evaluated by measur-
ing the absorbance at 260 and 280 nm (A260/280 ratio of
2.0; and an A260 of 1 being equal to 50 μg/ml), and the
appearance after electrophoretic resolution through a
1.8% (w/v) agarose-TBE gel, coresolving the samples
with l HindIII (1.25 μg) and 100 bp DNA ladder (0.5
μg) as DNA markers. After electrophoresis, the gel was
stained with 10 μg/ml of ethidium bromide (EtBr) for
10 min, destained in distilled water for 20 min and the
DNA visualized by ultraviolet transillumination.
Results
Crude extract of propolis from Apis mellifera
After sequential extraction of propolis with methanol,
CH2Cl2 and hexane, the three crude extracts obtained
(CME, CDE and CHE, respectively) varied in appear-
ance, yield and antiproliferative/cytotoxic bioactivities
(Table 1). Considering the order of the sequential
extraction, that the highest yield by far was found in the
last solvent extraction (CHE) means that it is likely to
be a realistic reflection that most of the extractable pro-
polis components were non-polar, although of course it
Table 1 The weight and character of crude A.mellifera
propolis extracts from Nan, Thailand
Fraction Weight
(mg)
%o f
initial
propolis
Character Antiproliferative/
cytotoxic
CHE 22,500 25.0% Dark brown,
sticky
Yes
CDE 1,320 1.47% Yellow brown,
sticky
Yes
CME 740 0.82% Hazel Weak (> 10 μg/ml)
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extracted in all three solvents. Nevertheless, the brown
pigments in propolis are, therefore seemingly non-polar,
whilst the viscous or sticky nature may represent the
wax.
Antiproliferative/cytotoxic activity
Effect of CHE, CDE and CME on different cancer cell lines
Five different cancer cell lines were used to screen for
the in vitro antiproliferative/cytotoxic activity of the
crude propolis extracts. Both the CHE and CDE
revealed a strong and broadly similar antiproliferative/
cytotoxic activity on all five cell lines in a dose-depen-
dent manner (Figure 1).
In terms of the antiproliferative/cytotoxic IC50 values,
the CHE and CDE were broadly numerically similar
across all five cell lines and between both extracts, ran-
ging from 41.3 μg/ml (CHE on Chaco) to 53.5 μg/ml
(CDE on Hep-G2) (Table 2). In contrast, the CME was
inactive at these concentrations showing a much weaker
antiproliferative/cytotoxic activity (Figure 1) with over
ten-fold higher IC50 values, ranging from 500 to 605 μg/
ml (Table 2).
Antiproliferative/cytotoxic effect of CHE fractions I - V on
the different cancer cell lines
Although the CHE and CDE presented very similar anti-
proliferative/cytotoxic activities against the five selected
cell lines, the yield of CHE was significantly (17-fold)
greater and thus was selected for further fractionation
by quick column chromatography. This yielded five frac-
tions of distinct compositions, as determined by the
TLC profile patterns, labeled as CHE fractions I - V,
with by far the highest yield being found in Fraction V
(4,300 mg), followed by fractions III and IV with a 13.4-
and 15.9- fold lower yield, respectively, whilst fractions I
and II were just minor components (Table 3).
As t r o n gin vitro antiproliferative/cytotoxic activity
against all five selected human cancer cell lines was
n o t e dw i t hf r a c t i o nV ,a n da g a i n s tt w oa n dt h r e eo ft h e
cell lines for fractions IV and II, respectively (Table 4
and Figure 2), but no significant activity was noted for
fractions I and II.
Of the three positive fractions, fraction V had the
highest antiproliferative/cytotoxic activity against each
of the five selected cancer cell lines, with IC50 values
ranging from 7.37 ± 0.23 μg/ml (SW260) to 29.36 ±
1.36 μg/ml (BT474). Fraction III showed broadly simi-
lar antiproliferative/cytotoxic activities, with IC50
values ranging from 13.69 ± 1.44 μg/ml (KATO-III) to
19.94 ± 1.83 μg/ml (SW620). Finally, fraction IV had
the lowest antiproliferative/cytotoxic activity of the
three positive fractions, and only on two of the five
tested cell lines with IC50 values of 40.16 ± 2.66 μg/ml
and 44.56 ± 1.89 μg/ml.
In vitro antiproliferative/cytotoxic effect of compounds 1
and 2 on the five different cancer cell lines
Since CHE fractions V and III showed the highest anti-
proliferative/cytotoxic activities on the five screened
human cancer cell lines, they were further purified by
adsorption chromatography, yielding 88 and 92 frac-
tions, respectively. However, in the TLC pattern profiles
of all these fractions two dominant spots were clearly
observed, one from CHE fraction III (compound 1) and
the other from CHE fraction V (compound 2). After
recovery from the TLC plates, compounds 1 and 2 were
found to both have a strong antiproliferative/cytotoxic
activity against the five different cancer cell lines in this
MTT assay (Figure 3). The derived IC50 values of com-
pound 1 for the SW620, KATO-III and BT474 cancer
cell lines were 1.53- to 1.98- fold lower than that for the
non-transformed Hs27 cell line, but in contrast, the IC50
values for the Hep-G2 and Chaco cancer cell lines were
e s s e n t i a l l yt h es a m ea st h eH s 2 7c e l ll i n e( T a b l e5 ) .
Thus, the antiproliferation/cytotoxic activity of com-
pound 1 on Hs27 is of concern.
Compound 2 had a higher antiproliferative/cytotoxic
activity than compound 1 for all five different cancer
cell lines (Figure 3), with IC50 values ranging from <
3.13 to 6.0 μg/ml (~6.82 to 13.1 μM) for the five differ-
ent cell lines, but it was equally effective against the
non-cancer Hs27 cell line (Table 5), which is again of
some concern for any potential in vivo application.
Structure analysis of compounds 1 and 2
Compounds 1 and 2 were analyzed by [
1H]-NMR and
ESI-MS spectroscopy. Compound 1 showed the charac-
teristic signals of an m-disubstituted benzene [δH 7.05
(1H, H-5), 6.67 (1H, H-6), 6.58 (1H, H-2), 6.57 (1H, H-
4)] and the characteristic resonances of the hydroxyl
group from the chemical shift of carbon at δC 155.4
ppm. In addition, resonances at δH 5.28 (2H, m) sug-
gested the presence of an olefinic proton. The Z-geome-
try of two olefinic protons, which were located at alkyl
side chain, was assigned from the chemical shift of
allylic carbons (δC 27.2 and 26.9). The presence of an
alkyl group (R-) was indicated by the signal of methy-
lenes (-CH2-) in the range of 1.2-2.5 ppm in addition to
the terminal methyl group [0.82 (3H, t, J = 6.8 Hz)].
The chain length could not be determined exactly due
to the lack of a calculated molecular mass, leaving an
incompletely deduced structural formula, but it was
categorized as a member of the cardanol group (Figure
4A).
T h em o l e c u l a rf o r m u l ao fc o m p o u n d2w a sr e v e a l e d
to be C31H54O2 by ESI-MS [m/z (M + H)
+], along with
the characteristic signals of a m-trisubstituted benzene
[δH 6.17 (2H, H-4, and H-6), 6.10 (1H, H-2)], and the
characteristic resonances of the hydroxyl group from the
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the symmetry. In addition, the resonances at δH 5.28
(2H, m) suggested the presence of olefinic protons. The
Z-geometry of two olefinic protons, which were located
at the alkyl side chain, was assigned from the chemical
shift of allylic carbons (δC 27.2 and 26.9). The presence
Figure 1 In vitro antiproliferative-cytotoxic activity of the (A) CHE, (B) CDE and (C) CME crude propolis extracts on five different
human cancer cell lines after exposure to the test extracts for 72 h. The data, as the percentage of viable cells relative to that of the
control, are expressed as the mean ± 1 SE.
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methylenes (-CH2-) in the range of 1.1-2.6 ppm in addi-
tion to thermal methyl [0.82 (3H, t, J = 6.8 Hz)]. From
the NMR and ESI-MS results compound 2 was ascribed
to be a member of the cardol group, although its exact
formula is unresolved (Figure 4B).
Morphology of the SW620 and Hs27 cells after in vitro
exposure to compound 1 (cardanol) or compound 2 (cardol)
SW620 cancer cell line
SW620 cells were cultured for up to 96 h in complete
medium supplemented with DMSO alone (control) or
the same amount of DMSO with either compound 1
(cardanol) or compound 2 (cardol) at their derived IC50
values for evaluation of their antiproliferation/cytotoxic
activity, namely at 10.76 and 3.0 μg/ml, respectively.
This is equivalent to 6.54 μM for compound 2, but the
molarity of compound 1 is unknown since its molecular
mass was not obtained. The cell morphology and cell
number were observed at 0, 24, 48, 72 and 96 h. As set
up (0 h), the cells looked flat and spindle shaped (Figure
5A). No significant change in the cell morphology was
observed in all samples, that is the solvent only control
and the cardanol and cardol treated cells, after 24 h of
treatment time with cells still appearing flat and in a
spindle shape (data not shown). However, after 48 h of
in vitro culture vacuolation could be seen inside the
cells treated with compound 1 or 2, but not in the con-
trol cells which were still normal (Figure 5).
By 72 h of cell culture, the control cells still appeared
normal (but more dense and approaching or reaching con-
fluency), whilst apparent DNA condensation within the
nucleus was visible in both the cardanol and cardol treated
cells (Figure 6). In addition, morphological changes and
cell debris (indicated by a red arrow) were visible, as well
as a reduced cell density compared to the control.
Finally, after 96 h of cell culture, whilst no change in
the morphology of the control cells was noted, signifi-
cantly higher levels of cells with DNA condensation
within their nucleus (red arrow) along with cell debris, a
loss of cell adhesion and a significantly reduced cell
number were clearly visible in the cardanol and cardol
treated cells (Figure 6).
Hs27 cells
In contrast to that observed for the SW620 cancer cell
line, no morphological changes were observed in the
non-transformed Hs27 cell line after similar in vitro
Table 2 The in vitro antiproliferative/cytotoxic IC50 values
of the CHE, CDE and CME on selected cancer cell lines
Cancer
cell lines
IC50 (μg/ml)
CHE CDE CME
BT474 48.3 ± 1.6
a 52.6 ± 3.7
a 500 ± 50
b
Chaco 41.3 ± 3.75
a 44.7 ± 0.33
a 580 ± 20
b
KATO-III 42.5 ± 6.61
a 43.8 ± 6.5
a 600 ± 50
b
SW620 45.3 ± 0.33
a 46.0 ± 0.57
a 555 ± 7.5
b
Hep-G2 52.4 ± 3.7
a 53.5 ± 0.5
a 605 ± 39.1
b
Data are shown as the mean ± 1 SE and are derived from three independent
repeats after a 72 h exposure to the test extracts. Means (within and between
columns) with a different lowercase superscript letter are significantly
different (p < 0.05; Kruskal-Wallis test)
Table 3 The yield and character of the five CHE fractions obtained after quick column chromatography
Fraction Weight (mg) Yield (% of
CHE/total propolis)
Character Antiproliferative/
cytotoxic activity
a
TLC plates
b
I 80 0.36%/0.09% Clear wax – 3
II 20 0.09%/0.02% Clear yellow oil – 3
III 320 1.42%/0.36% Yellow oil 3 cell lines 1
IV 270 1.2%/0.30% Yellow powder 2 cell lines 3
V 4,300 19.1%/4.78% Dark brown oil all 5 cell lines 2
aNumber of the five human cancer cell lines in which a significant antiproliferative/cytotoxic activity was induced by the extract after a 72 h exposure, as
determined by the MTT assay
bThe minimum number of distinct compounds in the fraction as determined by evaluation of the different TLC plates
Table 4 The IC50 values for the in vitro antiproliferation/
cytotoxic activity of CHE fractions I - IV on five human
cancer cell lines
Cancer
cell
lines
IC50 values (μg/ml)
Fraction
I
Fraction
II
Fraction III Fraction
IV
Fraction V
BT474 ND ND ND ND 29.36 ±
1.36
Chaco ND ND ND ND 12.75 ±
0.68
KATO-III ND ND 13.69 ±
1.44
a
40.16 ±
2.66
b
15.21 ±
2.13
a
SW620 ND ND 19.94 ±
1.83
b
44.56 ±
1.89
c
7.37 ±
0.23
a
Hep-G2 ND ND 19.37 ±
0.36
ND 22.22 ±
0.69
ND indicates no IC50 values were obtained since no significant
antiproliferative/cytotoxic activity was found in this tested concentration
range. Data is shown as the mean ± 1 SE from three independent repeats
after a 72 h exposure to the test compound. Means (within and between
columns) with a different lowercase superscript letter are significantly
different (p ≤ 0.05; Kruskal-Wallis test)
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Page 7 of 17treatment with the same doses of cardanol or cardol
(Figure 7). That is the cells looked flat and were
attached to the substratum at all time points in all three
treatments.
DNA Fragmentation
In order to find out whether compounds 1 and 2 (carda-
nol and cardol) could induce apoptosis or necrosis
through damage to the DNA of the cells in culture or
not, the DNA was extracted from cultured SW620 cells
a n de x a m i n e df o rs i z ef o l l o w i n gr e s o l u t i o nb ya g a r o s e -
TBE gel electrophoresis. If they play no role in DNA
damage, then the DNA would be expected to be intact
and appear as a high molecular weight and sharp band
following agarose - TBE electrophoresis, whereas, in
contrast, if significant damage to the DNA was induced
then a smear of fragmented DNA or a 180-200 bp inter-
val ladder (apoptosis) will be seen. Neither compound 1
(cardanol) nor compound 2 (cardol) treated SW620 cells
or the Hs27 cells revealed any evidence of fragmentation
of the DNA, neither as an apoptotic ladder nor a gen-
eral degradation smear (Figure 8).
From the analysis of the extracted DNA, which was a
large single band and not a 180-200 bp ladder or smear,
it is possible that compounds 1 and 2 did not kill the
cells by apoptosis since no DNA ladder pattern was
Figure 2 In vitro antiproliferative/cytotoxic activity of CHE fractions (A) III, (B) IV and (C) V on the five different cancer cell lines.T h e
antiproliferative/cytotoxic effect is expressed in terms of the percentage of viable cells relative to the control after 72 h exposure to the test
fractions, and is shown as the mean ± 1 SE.
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Page 8 of 17seen. In addition, no smear was found suggesting no sig-
nificant level of DNA damage. This does not contrast
with the notion of death by necrosis, as suggested by
the morphology changes, since the badly damaged
(necrotic) cells would have been removed in the washing
process during cell harvesting and before DNA
extraction.
Discussion
In this research, propolis from A. mellifera was used to
determine the in vitro antiproliferative/cytotoxic activity
on five human cancer cell lines. Although there are
many bee species that can produce propolis, especially
stingless bees, such as Melipona fasciculate:[ 3 0 ]a n d
Tetragonula carbonaria [31], A. mellifera was chosen
since it is commonly cultured for honey, is an easy to
manage species in apiaries and so makes access to pro-
polis on a commercial, as well as environmentally sus-
tainable, scale feasible. In addition, the bioactivities of
propolis are reported to depend on the geographical
regions [32], seasons [14] and other external factors.
Thus, the propolis of A. mellifera from Thailand, a floral
biodiversity hotspot, is of interest since it has never been
reported previously yet maybe different from the propo-
lis of this species reported previously from other
regions. The selection of Nan province was based upon
Figure 3 In vitro cytotoxic/antiproliferative activity of (A) compound 1 and (B) compound 2 on the five different cancer cell lines plus
the non-transformed Hs27 cell line. The antiproliferative/cytotoxic effect is expressed in terms of the percentage of viable cells relative to the
control after 72 h exposure to the test compound, and is shown as the mean ± 1 SE.
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Page 9 of 17the diverse flora still present in this region of Thailand,
and so the potential for novel compounds in the propo-
lis. This native and remote area of the country is dry,
mountainous and full of deep forests with unique plants,
such as Bretschneidera sinensis Hemsl.
Propolis was initially sequentially extracted with
MeOH (high-polar solvent), then CH2Cl2 (medium-
polar solvent) and finally hexane (non-polar solvent).
Both the hexane (CHE) and CH2Cl2 (CDE) extracts
revealed a good antiproliferative/cytotoxic activity
against the five selected human cancer cell lines, as
determined by the MTT assay. Thus, in general the
antiproliferative/cytotoxic compounds in this propolis
from A. mellifera in Nan, Thailand, are unlikely to be
highly polar. This notion is supported by Castro et al.
[33] who reported the best antiproliferative activity
against HeLa tumor cells was from prenylated benzo-
phenone (hyperibone A), which is found in the CHE of
Brazilian propolis, with an IC50 value of 175.6 nM (91
ng/ml).
Table 5 The in vitro antiproliferation/cytotoxic activity
IC50 values of compounds 1 and 2
Cancer
cell
lines
IC50 value
1
Compound 1 (μg/
ml)
2
Compound 2 (μg/ml/
μM)
BT474 13.95 ± 0.9 4.41 ±
0.15
9.61 ± 0.33
Chaco 29.30 ± 1.08 5.78 ±
0.07
12.60 ± 0.15
KATO-III 13.71 ± 1.42 4.03 ±
0.13
8.78 ± 0.28
SW620 10.76 ± 0.92 < 3.125 < 6.81
Hep-G2 21.53 ± 0.35 5.97 ±
0.15
1.30 ± 0.33
Hs27 21.35 ± 0.52 5.97 ±
0.15
1.30 ± 0.33
1 Data are shown as the mean ± 1 SE after a 72 h exposure to the test
compounds, and are derived from three independent experiments
2 The molar concentration of compound 1 could not be given as its molecular
formulae, and thus molar mass, is not known
Figure 4 The proposed formula structure of (A) compound 1, a cardanol and (B) compound 2, a cardol.
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could be used to extract the antioxidant activity from
propolis from Portugal [34], whilst other optimal extrac-
tion solvents were reported to be chloroform for the
antimicrobial activity against oral pathogens [30] and
ethanol for the anti-influenza A virus activity [35]. Thus,
the bioactivities of crude propolis extracts, and so the
frequently, albeit incorrectly, inferred propolis bioactiv-
ities, depend also on the extraction solvents used as
well.
The different cell line sensitivities and IC50 values for
the antiproliferative/cytotoxic activity before and after
fractionation by adsorption chromatography could repre-
sent the removal of inhibitory components that exert an
antagonistic effect, or the separation of different compo-
nents with different activities. Comparing the IC50 values
of compounds 1 and 2 (Table 5 and Figure 3), compound
2 (cardol) looked to be a promising agent for anti-cancer
treatment in terms of its lower IC50 values for antiproli-
feration/cytotoxicity compared to compound 1 (carda-
nol), assuming that (i) the same IC50 values observed
against the non-transformed Hs27 cell line reflects an
antiproliferative activity onlya n dn o tac y t o t o x i ca c t i v i t y
and that (ii) a specific delivery system could be used to
target the cancer cells or tumor area rather than systemic
delivery, so as to avoid or minimize side affects. More-
over, consumption of the crude form of propolis should
be warned against because Aliboni et al. [26] reported
that propolis can cause an allergic reaction to sensitive
individuals due to the presence of the two allergenic
esters, benzyl salicylate and benzyl cinnamate.
Both compounds 1 and 2 (cardanol and cardol) are
phenolic lipids with an amphiphilic character [36]
derived from the hydrophilic hydroxyl group and the
hydrophobic long chain hydrocarbon [37]. These com-
pounds are found in tropical plants in the family Ana-
cardiaceae, both in native and cultivated cultures [38].
Economic plants in this family include cashew nut,
mango and ginkgo [39], whilst the diversity of both
compounds is high, such as in the form of anacardic
acid, catechol, resorcinol and gingkolic acid [37]. Indeed,
members of these groups have previously been reported
to exhibit diverse bioactivities, such as antibacterial [40],
antiplasmodial [41], antioxidant [42] and antifungal
activities [43]. However, the diversity of chemical struc-
tures in the cardanol and cardol groups may account for
the diverse bioactivities [44], rather than a few pluripo-
tent compounds.
Wang et al. [45] reported that they could purify CAPE
from propolis, and that it showed an antiproliferative
Figure 5 SW620 cells after (A) 0 h culture and (B-D) after 48 h of culture with (B) the DMSO solvent alone (control) or with (C)
compound 1 (cardanol) at its IC50 value (10.76 μg/ml), or (D) compound 2 (cardol) at its IC50 value (3.0 μg/ml; 6.54 μM). All images are
magnified at 40×. Images shown are representative of at least five such fields of view per sample and three independent trials.
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Page 11 of 17activity on the human colorectal cancer cell line (CRC)
in a dose- and time-dependent manner. The IC50 value
of CAPE after 72 h treatment was 22.7 μM (6.47 μg/ml).
Comparing compound 2 (cardol) from our research with
that for CAPE, the antiproliferative/cytotoxic activity
IC50 value of compound 2 on the SW620 cell line (<
3.13 μg/ml; < 6.8 μM), which is also a human colorectal
cancer cell line, was over 3.3-fold lower than the IC50
value of CAPE on CRC (in terms of molarity). Thus,
subject to the risk of side effects, compound 2 (cardol)
purified from Thai A. mellifera propolis could be a bet-
ter antiproliferative agent against human colorectal can-
cer cells.
CAPE is also reported to have an effect on breast can-
cer cells, with a similar IC50 value on the ER
- and ER
+
MDA-231 and MCF-7 cell lines, respectively, of 15 μM
Figure 6 SW620 cells after (A-C) 72 h or (D-F) 96 h of culture in (A, D) the DMSO solvent alone (control) or (B, E) with compound 1
(cardanol) at its IC50 value (10.76 μg/ml), or (C, F) compound 2 (cardol) at its IC50 value (3.0 μg/ml; 6.54 μM). All images are magnified
at 40×. Images shown are representative of at least five such fields of view per sample and three independent trials.
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Page 12 of 17(4.26 μg/ml) [22]. Thus, the IC50 value reported for
CAPE is broadly similar in terms of mass, but some 1.5-
fold higher in terms of molarity, to that seen here for
compound 2 (cardol) against the breast cancer cell line
BT474 (4.41 μg/ml; 9.61 μM), again indicating that car-
dol purified from Thai A. mellifera propolis could be an
interesting antiproliferative agent against human breast
cancer cells.
CAPE has been reported to display a broad target
range inhibiting the growth of many cancer cell lines,
such as C6 glioma cells [46] and human leukemia (HL-
60) cells [47], and also to be cytotoxic to the neck
metastasis of gingiva carcinoma (GNM) and tongue
squamous cell carcinoma (TSCCa) cells [48]. Moreover,
CAPE showed a strong inhibitory effect on the matrix
metalloproteinase (MMP-9), which is related to the
invasion and metastasis ability of hepatocellular carcino-
mas [49]. In the future, the effect of compounds 1 (car-
danol) and 2 (cardol) from this Thai A. mellifera
propolis should be evaluated accordingly.
Since many cancer drugs or chemotherapy agents used
nowadays cause adverse side effects through being cyto-
toxic to normal cells, it is necessary to find new com-
pounds that will not cause such adverse side effects and
not be cytotoxic to normal cells. Therefore, the apparent
absence of cytotoxicity of compounds 1 (cardanol) and 2
(cardol) to the non-transformed Hs27 cell line in vitro is
of interest, but requires conformation in a broader
range of non-transformed cell lines. However, against
that was the observed antiproliferative affect noted on
the Hs27 cell line, which may well then result in strong
a d v e r s es i d ea f f e c t sa n ds ot h er e q u i r e m e n tf o rm o r e
localized drug delivery systems. This is because although
compounds 1 (cardanol) and 2 (cardol) affected some
cancer cell lines in vitro with lower IC50 values than
that against the non-transformed Hs27 cell line, this
small difference is unlikely to be sufficient to allow safe
systemic administration without side affects, but may be
sufficient when targeted local delivery is performed
[50,51].
Propolis and its phenolic compounds have been
reported to induce the death of cancer cells either by
necrosis [52] or by apoptosis, the latter of which might
be by mitochondria mediated- [21] or death signal
mediated- [53] apoptosis. Thus, the in vitro effects of
compounds 1 and 2 upon the cell morphology and
DNA fragmentation of the cell lines was observed.
A change in the cell morphology with a decrease in
the cell number was observed for SW620 cells when
cultured in vitro with compounds 1 (cardanol) or 2 (car-
dol), which is consistent with a cytotoxic effect. In con-
trast, no change in the cell morphology was observed
with the Hs27 cells under the same conditions. It is
likely that compounds 1 (cardanol) and 2 (cardol)
Figure 7 The shape of Hs27 cells at (A) 0 h and (B-D) 96 h of in vitro culture with (A, B) DMSO solvent only (control), (C) compound 1
(cardanol) at its IC50 value (10.76 μg/ml)and (D) compound 2 (cardol) at its IC50 value (3.0 μg/ml; 6.54 μM). All images were magnified
at 40×. Images shown are representative of at least five such fields of view per sample and three independent trials.
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apoptosis, whereas they induced an antiproliferation
response and not cell death in the Hs27 cells. In con-
trast, Vatansever et al. [54] reported that CEE from Tur-
key induced the death of the human breast cancer cell
line (MCF-7) by the induction of apoptosis. Although
the morphology of the MCF-7 cells was not visibly
changed, the number of cells was decreased. In addition,
whilst Umthong et al. [55] found that CWE and CME
from Trigona laeviceps (stingless bee) in Samut Songk-
ram province, Thailand, had a similar effect upon
SW620 cells as that reported here (change in the cell
morphology, loss of cell adhesion and cell death), in
contrast, they found evidence of DNA fragmentation,
unlike in this study with compounds 1 (cardanol) or 2
(cardol). Moreover, Chen et al. [56] reported that propo-
lins A and B extracted from Taiwanese propolis could
induce apoptosis of human melanoma A2058 cells, in
addition to inducing the morphological changes in the
cells, chromatin condensation and cell shrinkage. How-
ever, since we did not screen the crude extracts for
changes in the cell morphology and DNA damage, but
only the two purified compounds that were not propolin
A or B, then it is unclear if this represents the diversity
of bioactivity within different propolis components or
between propolis samples.
Cancer can be caused by the misregulation of, and so
its treatment can be targeted at inhibition of, phosphati-
dylinositol-specific phospholipase Cg1( P I - P L C g1), since
it plays a key role in the proliferation and progression of
human cancer [57]. Thus, an inhibitor of PI-PLCg1
would be a useful tool for development of anticancer
agents. Lee et al. [58] reported the isolation of a carda-
nol from the chloroform extract of Ginko biloba that
exhibited inhibitory effects against PI-PLCg1i nac o n -
centration-dependent manner. They also found that the
structure of the cardanol could influence the inhibitory
effect. Cardanol with unsaturated long carbon chains
(cardanol C15:1 and cardanol C17:1) showed more potent
activities than those with saturated long chains (carda-
nol C13:0 and cardanol C15:0). Other than the inhibition
on PI-PLCg1, cardanol is reported to be cytotoxic in
vitro to human cancer cell lines, such as HCT-15
(colon), MCF-7 (breast), A-549 (lung), HT-1197 (blad-
der) and SKOV-3 (ovary), but was not found to be cyto-
toxic to the normal colon cell line, CCD-18-Co.
In addition, Kubo et al. [59] reported that the cardol
(C15:0)i s o l a t e df r o mAnacardium occidentale was
Figure 8 Agarose (1.8% (w/v))-TBE gel electrophoresis of 1 μg DNA (per lane) extracted from (A) SW620 and (B) Hs27 cells after 72 h
in vitro culture in complete medium supplemented with (Lane 1) DMSO solvent only (control), (Lane 2) compound 1 (cardanol) at its
IC50 value (10.76 μg/ml) and (Lane 3) compound 2 (cardol) at its IC50 value (3.0 μg/ml). Lanes M1 and M2 contain l Hind III and 100 bp
ladders, respectively, as DNA size markers.
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Page 14 of 17moderately cytotoxic to the murine B16-F10 melanoma
cells in a dose-dependent manner with an IC50 value of
24 μM (8.352 μg/ml) and complete lethality at 40 μM
(13.92 μg/ml), which in terms of molarity is some two-
to 3.5- fold higher than that observed here for com-
pound 2 (cardol) from the Thai A. mellifera propolis
(albeit subject to the caveat of on different cell lines).
Since cardol is an amphipathic molecule, the cytotoxi-
city is potentially facilitated by its ability to act as a
surfactant.
The two potentially new compounds isolated here
from Thai A. mellifera propolis (a cardanol and a car-
dol) could be alternative antiproliferative agents for
future development as anti-cancer drugs.
Conclusion
Propolis of A. mellifera was focused upon in this
research due to the wide cultivated distribution of this
bee species in Thailand, a floral biodiversity hotspot.
The location of Nan province was accordingly selected
due to the native and remote area of the country. Since
the crude hexane and dichloromethane extracts of pro-
polis provided a good in vitro antiproliferation/cytotoxi-
city against the selected cancer cell lines, it indicated
that the polarity of the active compounds is likely to be
low. Considering the cell line sensitivities and IC50
values for the antiproliferation/cytotoxicity before and
after each fractionation, application of the active crude
extracts is more interesting. After purification and che-
mical structure analysis, one member of each of the car-
danol and cardol groups, as phenolic compounds, were
revealed. The apparent absence of cytotoxicity of both
compounds to the normal Hs27 cell line in vitro is of
interest since many cancer drugs or chemotherapy
agents used nowadays cause adverse side effects through
being cytotoxic to normal cells. Considering the cell
morphology, cell number and the cytotoxic effect, it is
likely that both compounds affected the SW620 cancer
cells by necrosis.
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